What are the treatment options for keloid management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keloid Management: Treatment Options

Intralesional triamcinolone acetonide (10-40 mg/mL) is the first-line treatment for keloids, with higher concentrations (40 mg/mL) recommended for established lesions, and this can be combined with silicone gel or sheeting for optimal outcomes. 1, 2, 3

First-Line Treatment Approach

Intralesional Corticosteroids

  • Triamcinolone acetonide is FDA-approved for intralesional keloid treatment and represents the most commonly used first-line therapy 2
  • Use concentrations of 10-40 mg/mL, with 40 mg/mL specifically recommended for hypertrophic scars and keloids 1
  • Monthly injections are the standard administration schedule 4
  • Monitor for local adverse effects including atrophy, pigmentary changes, telangiectasias, and hypertrichosis, as well as systemic absorption with repeated injections 1
  • Post-operative steroid injections reduce keloid recurrence to less than 50% 5

Adjunctive Silicone Therapy

  • Silicone gel or sheeting should be used in combination with corticosteroid injections as first-line therapy 3
  • The therapeutic effect results from occlusion and hydration rather than the silicone material itself 5
  • Silicone sheeting has evidence for reducing keloid recurrence 3

Alternative First-Line Option for Needle-Phobic Patients

  • Topical clobetasol propionate 0.05% cream under occlusion with silicone dressing (applied daily) is equally effective to intralesional triamcinolone with significantly fewer adverse effects 4
  • This approach causes less pain, erythema (17.6% vs 41.2%), hypopigmentation (23.5% vs 35.3%), telangiectasia (17.6% vs 41.2%), and skin atrophy (5.9% vs 23.5%) compared to intralesional injections 4

Second-Line Adjunctive Intralesional Agents

When corticosteroids alone are insufficient, consider adding:

  • 5-fluorouracil (5-FU): Can be used as adjunctive intralesional therapy, though results are mixed 3
  • Bleomycin: Another intralesional option with variable efficacy 3
  • Verapamil: Can be considered as adjunctive intralesional treatment 3

Cryotherapy

  • Cryosurgery with liquid nitrogen is effective for small keloids 6
  • Apply for 15-20 seconds until 1-2 mm of surrounding skin appears frozen, followed by 20-60 second thawing, then repeat the cycle 6
  • Combined cryotherapy immediately followed by intralesional corticosteroid injection achieves superior success rates of 89-91% 6

Laser Therapy

  • Laser therapy should be used in combination with intralesional corticosteroids or topical steroids with occlusion to improve drug penetration 3
  • The pulsed-dye laser offers symptomatic improvement and reduces erythema associated with keloids 5
  • CO2 ablative fractional resurfacing laser has been used, though it may fail as monotherapy 7

Surgical Excision with Radiation

  • Excision combined with immediate post-excision radiation therapy is the most effective option for recalcitrant lesions 3
  • Excision alone results in 45-100% recurrence rates and should be avoided 5
  • A combined approach of trepanation and superficial radiotherapy has shown success with no recurrence at 3-year follow-up 7

Emerging Therapies

  • Interferon alpha-2b applied to post-surgical excised keloids shows 18% recurrence rate 8
  • Imiquimod 5% can lower recurrence rates on post-shaved keloids to 37.5% at 6 months and 0% at 12 months 8
  • Imiquimod upregulates interferons that inhibit collagen production by fibroblasts 9

Prevention Strategies

  • Individuals with personal or family history of keloids must be counseled about the risk of any procedure causing skin trauma, as prevention is the best strategy 1, 6
  • UV protection is fundamental, as sun exposure worsens keloid scars 6
  • Pressure therapy has evidence for reducing keloid recurrence 3

Infection Management

  • Treat infections with standard topical or systemic antibiotics as you would other skin and soft tissue infections 1, 6

Common Pitfalls

  • Avoid excision as monotherapy—recurrence rates are unacceptably high without adjunctive radiation 5
  • Ear keloids require special consideration due to higher recurrence risk 6
  • All patients receiving intralesional corticosteroids require monitoring for both local and systemic adverse effects 1

References

Guideline

Keloid Management: Treatment Options

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The treatment of hypertrophic scars and keloids.

European journal of dermatology : EJD, 1998

Guideline

Tratamiento de Cicatrices Queloides

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.